Organization
University of Kentucky Markey Cancer Center
5 abstracts
Abstract
A prognostic model based on selected cell state and cellular community scores in patients with advanced melanoma treated with immune checkpoint inhibitors (Ecotype-ICI score) as a predictor of ICI immunotherapeutic benefits.Org: Huntsman Cancer Institute and Department of Neurosurgery, University of Kentucky Markey Cancer Center, University of Iowa Hospitals and Clinics Holden Comprehensive Cancer Center, Division of Cancer Treatment and Diagnosis National Cancer Institute National Institutes of Health, Melanoma Program UPMC Hillman Cancer Center,
Abstract
Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes.Org: H. Lee Moffitt Cancer Center and Research Institute, Ohio State University Comprehensive Cancer Center, University of Virginia, Charlottesville, VA, USA, University of Colorado Denver Anschutz Medical Center, University of Southern California - Health Sciences Campus,
Abstract
Impact of best practice advisory on genetic counseling referral patterns for patients with endometrial cancer.Org: University of Kentucky Medical Center, Department of Information Technology, University of Kentucky Chandler Medical Center, University of Kentucky College of Medicine, University of Kentucky Markey Cancer Center,
Abstract
Clinical utility of reporting research genetic predisposition testing results to Total Cancer Care participants.Org: University of Kentucky Markey Cancer Center, University of Kentucky Chandler Medical Center, University of Kentucky, Lexington, KY, Department of Pathology and Laboratory Medicine University of Kentucky Chandler Medical Center, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University of Kentucky College of Medicine,
Abstract
Update on the outcome of patients with metastatic prostate cancer in Kentucky: A Kentucky Cancer Registry (KCR) study.Org: University of Kentucky, Lexington, KY, Markey Cancer Center, University of Kentucky, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, University of Kentucky Markey Cancer Center,